Trademark Search in Canada

ERAVMIO

View On IC.GC.CA

REGISTERED

on 12 Feb 2024

Last Applicant/ Owned by

JOHNSON & JOHNSON

One Johnson & Johnson PlazaNew Brunswick, NJ 08933-7001

Serial Number

2059827 filed on 26^th Oct 2020

Registration Number

TMA1221087 registered on 12^th Feb 2024

Registration expiry Date

12^th Feb 2034

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

ERAVMIO

Trademark usage description

human pharmaceuticals for the prevention or treatment of auto-immune diseases, pulmonary diseases, cardiovascular diseases, gastro-intestinal diseases Read More

Classification Information

Class [005]
Human pharmaceuticals for the prevention or treatment of auto-immune diseases, pulmonary diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; antivirals; anti-inflammatory medications; anti-pain medications; and anti-infective medications; human vaccines

Classification kind code

Mark Details

Serial Number

2059827

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 22^nd Nov 2023	Advertised
Submitted for opposition 26 on 30^th Oct 2023	Approved
Submitted for opposition 27 on 30^th Oct 2023	Approval Notice Sent
Submitted for opposition 15 on 3^rd Aug 2023	Correspondence Created
Submitted for opposition 22 on 2^th Feb 2023	Search Recorded
Submitted for opposition 20 on 2^th Feb 2023	Examiner's First Report
Submitted for opposition 287 on 22^nd Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 26^th Oct 2020	Filed
Submitted for opposition 1 on 26^th Oct 2020	Created
Submitted for opposition 31 on 26^th Oct 2020	Formalized